# Transcatheter tricuspid valve replacement using the LuX‐Valve Plus system: 1‐year compassionate use outcomes

**Authors:** Lukas Stolz, Neil Fam, Geraldine Ong, Pedro Villablanca, Ahmad Jabri, Ole de Backer, Jacob Eifer Mølller, Didier Tchétché, Omar Oliva, Kent Chak‐Yu So, Yat‐Yin Lam, Azeem Latib, Edwin C. Ho, Andrea Scotti, Augustin Coisne, Arnaud Sudre, Julien Dreyfus, Mohammed Nejjari, Ignacio Cruz‐Gonzalez, Rodrigo Estévez‐Loureiro, Manuel Barreiro‐Perez, Guillaume Leurent, Erwan Donal, Guillaume Bonnet, Thomas Modine, Raj Makkar, Dhairya Patel, Karl‐Patrik Kresoja, Philipp Lurz, Jörg Hausleiter

PMC · DOI: 10.1002/ejhf.70010 · 2025-08-18

## Full-text entities

- **Genes:** F2R (coagulation factor II thrombin receptor) [NCBI Gene 2149] {aka CF2R, HTR, PAR-1, PAR1, TR}
- **Diseases:** valve thrombosis (MESH:D006349), TR (MESH:D014262), bleeding (MESH:D006470), peripheral oedema (MESH:D010523), pulmonary embolism (MESH:D011655), ascites (MESH:D001201), stroke (MESH:D020521), RV reverse remodelling (MESH:D020257), right ventricular (RV) failure (MESH:D051437), hypertension (MESH:D006973), coronary artery disease (MESH:D003324), myocardial infarction (MESH:D009203), pleural effusion (MESH:D010996), Cardiomyopathy (MESH:D009202), atrial fibrillation (MESH:D001281), HFH (MESH:D006333)
- **Chemicals:** oral anticoagulants (-), acetylsalicylic acid (MESH:D001241)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12765459/full.md

---
Source: https://tomesphere.com/paper/PMC12765459